Description
CJC-1295 (Growth Hormone Releasing Hormone Analog)
CJC-1295 is a synthetic peptide and analog of Growth Hormone Releasing Hormone (GHRH). It is designed to stimulate the pituitary gland to release growth hormone (GH) and increase Insulin-like Growth Factor 1 (IGF-1) levels. Unlike natural GHRH, CJC-1295 has been modified with a Drug Affinity Complex (DAC) to significantly extend its half-life and duration of action.
Research Properties:
- Growth Hormone Stimulation: Studied for its ability to elevate growth hormone secretion and IGF-1 levels.
- Muscle & Tissue Research: Investigated for its potential effects on muscle growth, recovery, and body composition.
- Metabolic Effects: Researched for possible roles in fat metabolism and overall metabolic function.
- Anti-Aging & Recovery: Explored in studies related to tissue repair, sleep quality, and age-related decline.
Administration in Research:
- Subcutaneous injection
- Typically studied in evening or early morning administrations
For Research Use Only. Not for human consumption. CJC-1295 is intended strictly for laboratory research and in-vitro experimentation.







Reviews
There are no reviews yet.